Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Alina Brandes (3400352)
Florian Koerber (3400355)
Larissa Schwarzkopf (3400349)
Matthias Hunger (712921)
Wolf Rogowski (3400358)
Raphaela Waidelich (296617)

Open link

Publication date

November 2016

DOI

10.6084/m9.figshare.c.3596096_d1.v1

Abstract

Diagnostic codes for cohort selection. Table S2. Procedure codes for cohort selection. (DOC 34 kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Alina Brandes (3400352)
Florian Koerber (3400355)
Larissa Schwarzkopf (3400349)
Matthias Hunger (712921)
Wolf Rogowski (3400358)
Raphaela Waidelich (296617)

Open link

Publication date

November 2016

DOI

10.6084/m9.figshare.c.3596096_d1.v1

Abstract

Diagnostic codes for cohort selection. Table S2. Procedure codes for cohort selection. (DOC 34 kb

Extracted data

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Programmeâs clinical eligibility criteria. Table containing the clinical eligibility criteria for ...

Additional file 1: Table S1. of Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

Wolfgang Lilleby (3528701)
Amol Narrang (3528707)
Gunnar Tafjord (3528692)
Ljiljana Vlatkovic (411863)
Kjell Russnes (3528704)
Andreas Stensvold (3528713)
Knut Hole (3528710)
Phuoc Tran (3528698)
Karsten Eilertsen (3528695)

November 2015

Univariate Cox proportional hazards analysis for associations between covariates and survival endpoi...

Additional file 1: of Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study

Anouk Aa (6595157)
Christophe Mannaerts (6595163)
Maudy Gayet (6595166)
Johannes Linden (6595169)
Barthold Schrier (6595172)
J. Sedelaar (6553610)
Massimo Mischi (3496289)
Harrie Beerlage (6595175)
Hessel Wijkstra (6595178)

April 2019

Table S1. Univariate and multivariate logistic regression analyses of individual risk factors for de...

Additional file 1: Tables S1 â S6. of Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

Carolina Bonilla (116077)
Sarah Lewis (70866)
Richard Martin (817808)
Jenny Donovan (360643)
Freddie Hamdy (360644)
David Neal (360645)
Rosalind Eeles (154187)
Doug Easton (553718)
Zsofia Kote-Jarai (69444)
Ali Al Olama (3452108)
Sara Benlloch (523055)
Kenneth Muir (194882)
Graham Giles (521929)
Fredrik Wiklund (372507)
Henrik Gronberg (3452111)
Christopher Haiman (120857)
Johanna Schleutker (200707)
BĂ¸rge Nordestgaard (3452126)
Ruth Travis (151267)
Nora Pashayan (64158)
Kay-Tee Khaw (110271)
Janet Stanford (3435146)
William Blot (3074559)
Stephen Thibodeau (3452099)
Christiane Maier (328509)
Adam Kibel (3452102)
Cezary Cybulski (196608)
Lisa Cannon-Albright (523061)
Hermann Brenner (63649)
Jong Park (118816)
Radka Kaneva (523062)
Jyotsna Batra (138092)
Manuel Teixeira (3405287)
Hardev Pandha (3452105)
Mark Lathrop (17971)
George Davey Smith (82619)

April 2016

Figures S1âS4. Supplementary Methods. Definitions. Supplementary References. (DOCX 214 kb

Additional file 1: of Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

Hla-Hla Thein (151401)
Nathaniel Jembere (151374)
Kednapa Thavorn (811567)
Kelvin Chan (640315)
Peter Coyte (4256980)
Claire de Oliveira (3539588)
Chin Hur (252392)
Craig Earle (151397)

June 2018

Materials and Methods. Table S1. Fee codes used to define types of treatment for esophageal adenocar...

Additional file 2: of Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis

Leslie Wilson (32629)
Traci Blonquist (6192938)
Fangxin Hong (26251)
Barbara Halpenny (6192941)
Seth Wolpin (6192947)
Peter Chang (153006)
Christopher Filson (6192950)
Viraj Master (6192953)
Martin Sanda (2400070)
Gary Chien (6192956)
Randy Jones (6192959)
Tracey Krupski (6192962)
Donna Berry (6192965)

January 2019

Table S2. Tobit Regression Model for P3P Intervention- All Values <$100,000. Table detailing the sta...

Additional file 1: of Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis

Leslie Wilson (32629)
Traci Blonquist (6192938)
Fangxin Hong (26251)
Barbara Halpenny (6192941)
Seth Wolpin (6192947)
Peter Chang (153006)
Christopher Filson (6192950)
Viraj Master (6192953)
Martin Sanda (2400070)
Gary Chien (6192956)
Randy Jones (6192959)
Tracey Krupski (6192962)
Donna Berry (6192965)

January 2019

Table S1. Actual, Transformed and Back-Transformed Willingness to Pay values for P3P and Usual Care ...

Additional file 2: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Frequency of service use for programme and comparator groups. Table containing frequency of service ...

Additional file 1: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

V. Gnanapragasam (4402468)
O. Bratt (4901767)
K. Muir (3562337)
L. Lee (4901773)
H. Huang (3050796)
P. Stattin (4901770)
A. Lophatananon (4901776)

February 2018

Table S1. Use of treatments according to Cambridge Prognostic Group (CPG) in the PCBaSe cohort. (DOC...

Additional file 2: Table S2A. of Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

Beate Jahn (170765)
Ursula Rochau (2553013)
Christina Kurzthaler (4516393)
Michael Hubalek (102610)
Rebecca Miksad (4516387)
Gaby Sroczynski (4516390)
Mike Paulden (4516396)
Marvin Bundo (4516399)
David Stenehjem (3455345)
Diana Brixner (3455348)
Murray Krahn (250684)
Uwe Siebert (495818)

October 2017

Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...

Additional file 6: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

V. Gnanapragasam (4402468)
O. Bratt (4901767)
K. Muir (3562337)
L. Lee (4901773)
H. Huang (3050796)
P. Stattin (4901770)
A. Lophatananon (4901776)

February 2018

Table S6. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge...

Additional file 4: Table S2C. of Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

Beate Jahn (170765)
Ursula Rochau (2553013)
Christina Kurzthaler (4516393)
Michael Hubalek (102610)
Rebecca Miksad (4516387)
Gaby Sroczynski (4516390)
Mike Paulden (4516396)
Marvin Bundo (4516399)
David Stenehjem (3455345)
Diana Brixner (3455348)
Murray Krahn (250684)
Uwe Siebert (495818)

October 2017

Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a high risk according t...

Additional file 3: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Unit costs used in calculation of provision of follow-up care and other prostate cancer related serv...

Additional file 1: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Programmeâs clinical eligibility criteria. Table containing the clinical eligibility criteria for ...

Additional file 1: Table S1. of Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

Wolfgang Lilleby (3528701)
Amol Narrang (3528707)
Gunnar Tafjord (3528692)
Ljiljana Vlatkovic (411863)
Kjell Russnes (3528704)
Andreas Stensvold (3528713)
Knut Hole (3528710)
Phuoc Tran (3528698)
Karsten Eilertsen (3528695)

November 2015

Univariate Cox proportional hazards analysis for associations between covariates and survival endpoi...

Additional file 1: of Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study

Anouk Aa (6595157)
Christophe Mannaerts (6595163)
Maudy Gayet (6595166)
Johannes Linden (6595169)
Barthold Schrier (6595172)
J. Sedelaar (6553610)
Massimo Mischi (3496289)
Harrie Beerlage (6595175)
Hessel Wijkstra (6595178)

April 2019

Table S1. Univariate and multivariate logistic regression analyses of individual risk factors for de...

Additional file 1: Tables S1 â S6. of Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

Carolina Bonilla (116077)
Sarah Lewis (70866)
Richard Martin (817808)
Jenny Donovan (360643)
Freddie Hamdy (360644)
David Neal (360645)
Rosalind Eeles (154187)
Doug Easton (553718)
Zsofia Kote-Jarai (69444)
Ali Al Olama (3452108)
Sara Benlloch (523055)
Kenneth Muir (194882)
Graham Giles (521929)
Fredrik Wiklund (372507)
Henrik Gronberg (3452111)
Christopher Haiman (120857)
Johanna Schleutker (200707)
BĂ¸rge Nordestgaard (3452126)
Ruth Travis (151267)
Nora Pashayan (64158)
Kay-Tee Khaw (110271)
Janet Stanford (3435146)
William Blot (3074559)
Stephen Thibodeau (3452099)
Christiane Maier (328509)
Adam Kibel (3452102)
Cezary Cybulski (196608)
Lisa Cannon-Albright (523061)
Hermann Brenner (63649)
Jong Park (118816)
Radka Kaneva (523062)
Jyotsna Batra (138092)
Manuel Teixeira (3405287)
Hardev Pandha (3452105)
Mark Lathrop (17971)
George Davey Smith (82619)

April 2016

Figures S1âS4. Supplementary Methods. Definitions. Supplementary References. (DOCX 214 kb

Additional file 1: of Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

Hla-Hla Thein (151401)
Nathaniel Jembere (151374)
Kednapa Thavorn (811567)
Kelvin Chan (640315)
Peter Coyte (4256980)
Claire de Oliveira (3539588)
Chin Hur (252392)
Craig Earle (151397)

June 2018

Materials and Methods. Table S1. Fee codes used to define types of treatment for esophageal adenocar...

Additional file 2: of Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis

Leslie Wilson (32629)
Traci Blonquist (6192938)
Fangxin Hong (26251)
Barbara Halpenny (6192941)
Seth Wolpin (6192947)
Peter Chang (153006)
Christopher Filson (6192950)
Viraj Master (6192953)
Martin Sanda (2400070)
Gary Chien (6192956)
Randy Jones (6192959)
Tracey Krupski (6192962)
Donna Berry (6192965)

January 2019

Table S2. Tobit Regression Model for P3P Intervention- All Values <$100,000. Table detailing the sta...

Additional file 1: of Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis

Leslie Wilson (32629)
Traci Blonquist (6192938)
Fangxin Hong (26251)
Barbara Halpenny (6192941)
Seth Wolpin (6192947)
Peter Chang (153006)
Christopher Filson (6192950)
Viraj Master (6192953)
Martin Sanda (2400070)
Gary Chien (6192956)
Randy Jones (6192959)
Tracey Krupski (6192962)
Donna Berry (6192965)

January 2019

Table S1. Actual, Transformed and Back-Transformed Willingness to Pay values for P3P and Usual Care ...

Additional file 2: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Frequency of service use for programme and comparator groups. Table containing frequency of service ...

Additional file 1: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

V. Gnanapragasam (4402468)
O. Bratt (4901767)
K. Muir (3562337)
L. Lee (4901773)
H. Huang (3050796)
P. Stattin (4901770)
A. Lophatananon (4901776)

February 2018

Table S1. Use of treatments according to Cambridge Prognostic Group (CPG) in the PCBaSe cohort. (DOC...

Beate Jahn (170765)
Ursula Rochau (2553013)
Christina Kurzthaler (4516393)
Michael Hubalek (102610)
Rebecca Miksad (4516387)
Gaby Sroczynski (4516390)
Mike Paulden (4516396)
Marvin Bundo (4516399)
David Stenehjem (3455345)
Diana Brixner (3455348)
Murray Krahn (250684)
Uwe Siebert (495818)

October 2017

Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...

Additional file 6: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

V. Gnanapragasam (4402468)
O. Bratt (4901767)
K. Muir (3562337)
L. Lee (4901773)
H. Huang (3050796)
P. Stattin (4901770)
A. Lophatananon (4901776)

February 2018

Table S6. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge...

Beate Jahn (170765)
Ursula Rochau (2553013)
Christina Kurzthaler (4516393)
Michael Hubalek (102610)
Rebecca Miksad (4516387)
Gaby Sroczynski (4516390)
Mike Paulden (4516396)
Marvin Bundo (4516399)
David Stenehjem (3455345)
Diana Brixner (3455348)
Murray Krahn (250684)
Uwe Siebert (495818)

October 2017

Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a high risk according t...

Additional file 3: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Unit costs used in calculation of provision of follow-up care and other prostate cancer related serv...

Additional file 1: of Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme

Jane Frankland (4447327)
Hazel Brodie (4447321)
Deborah Cooke (4447324)
Claire Foster (768031)
Rebecca Foster (137482)
Heather Gage (4447318)
Jake Jordan (4447315)
Ines Mesa-Eguiagaray (3527063)
Ruth Pickering (2945538)
Alison Richardson (697756)

April 2019

Programmeâs clinical eligibility criteria. Table containing the clinical eligibility criteria for ...

Additional file 1: Table S1. of Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

Wolfgang Lilleby (3528701)
Amol Narrang (3528707)
Gunnar Tafjord (3528692)
Ljiljana Vlatkovic (411863)
Kjell Russnes (3528704)
Andreas Stensvold (3528713)
Knut Hole (3528710)
Phuoc Tran (3528698)
Karsten Eilertsen (3528695)

November 2015

Univariate Cox proportional hazards analysis for associations between covariates and survival endpoi...

Additional file 1: of Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study

Anouk Aa (6595157)
Christophe Mannaerts (6595163)
Maudy Gayet (6595166)
Johannes Linden (6595169)
Barthold Schrier (6595172)
J. Sedelaar (6553610)
Massimo Mischi (3496289)
Harrie Beerlage (6595175)
Hessel Wijkstra (6595178)

April 2019

Table S1. Univariate and multivariate logistic regression analyses of individual risk factors for de...

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Abstract

Extracted data

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Abstract

Extracted data

Related items

Related items

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Abstract

Extracted data

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Abstract

Extracted data

Related items

Related items

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis

Additional file 1: Table S1. of Costs of conservative management of early-stage prostate cancer compared to radical prostatectomyâa claims data analysis